Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

26d ago, source: Stockhouse

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the Compensation ...

Kezar Life Sciences Inc

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

26d ago, source: The Bakersfield Californian

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the ...

Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

26d ago, source: Yahoo Finance

SOUTH SAN FRANCISCO, Calif., April 08, 2024--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments for immune-mediated ...

Kezar Life Sciences Inc (KZR)

8d ago, source: Investing

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...